Chronic Renal Failure clinical trials

Explore recruiting chronic renal failure clinical trials.

Recruiting chronic renal failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Renal Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evolution of proteinuria in renal transplant patients treated with Dapagliflozin for nephroprotection. DAPAGREFFE

France

Therapeutic use (Phase IV) EU CTIS Study details

ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut Microbiota modulations After kidney transplantation - ENIGMA

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Interest of belatacept as a non-nephrotoxic immunosuppressive treatment in cardiac transplant patients at risk of chronic renal failure.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Eight-Treg study: a phase I dose escalation trial of adoptive immunotherapy with autologous ex vivo expanded regulatory CD8+ T cells in living donor kidney transplant recipients

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Study in healthy male participants to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as multiple intravenous injections as well as safety, tolerability and the effects on certain blood values.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Study in healthy volunteers to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as a single intravenous injection as well as safety, tolerability and the effects on certain blood values.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Chronic Renal Failure trials by city

Chronic Renal Failure in Toronto Chronic Renal Failure in Vancouver Chronic Renal Failure in Montreal Chronic Renal Failure in Calgary Chronic Renal Failure in Edmonton Chronic Renal Failure in Ottawa Chronic Renal Failure in Winnipeg Chronic Renal Failure in Quebec City Chronic Renal Failure in Hamilton Chronic Renal Failure in Kitchener Chronic Renal Failure in London Chronic Renal Failure in Halifax Chronic Renal Failure in New York Chronic Renal Failure in Los Angeles Chronic Renal Failure in Chicago Chronic Renal Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease